Marion Kiechle

27PUBLICATIONS
146CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingCancer geneticsMolecular targetsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 27, 2026
Kallikrein-Related Peptidase 5 Is Associated with Tumor Progression, KRT19 Expression, and Distinct Molecular Programs in High-Grade Serous Ovarian Cancer.

|Sep 26, 2026
Digitalization in Breast Cancer Care: Health App Use and Patient Needs-A Cross-Sectional Survey.

|Aug 26, 2026
Patients' Perspectives on Changes in Cancer Care During the COVID-19 Pandemic: Results of a Survey Among Patients with Gynecological Malignancies and Breast Cancer in Germany (NOGGO-S25/Expression XIII).

|Apr 24, 2026
High uPAR and Low miR-221 Expression Predict Poor Disease-Free Survival in Triple-Negative Breast Cancer.

|Mar 09, 2026
Risk of Breast and Ovarian Cancer After Prophylactic Mastectomy and Salpingo-Oophorectomy in BRCA1/2 Germline Variant Carriers: A Retrospective Cohort Study From a Single German Center.

Sara Mendes, Maryam Yahiaoui-Doktor, Eva Maria Fallenberg

|Jun 27, 2025
PARP inhibitor-induced anti-tumour chemokine response is suppressed by dipeptidyl peptidase 4 (DPP4) in ovarian cancer.

Christoph Stange, Tobias F Dreyer, Maximilian Riedel

Pageof 5

Frequent Collaborators

5 joint publications

Tobias F Dreyer

4 joint publications

Holger Bronger

4 joint publications

Viktor Magdolen

2 joint publications

Stephan C Bischoff